Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which's better?1 passage
• Bidirectional associations among gallstone disease, non-alcoholic fatty liver disease, kidney stone disease1 passage
• Diagnosis and treatment of iron-deficiency anemia in gastrointestinal bleeding: A systematic review1 passage
• Efficacy and safety of triple therapy with vonoprazan for Helicobacter pylori eradication: A multicenter, prospective, randomized controlled trial1 passage
• Efficacy of indomethacin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A comprehensive meta-analysis of randomized controlled trials1 passage
• Helicobacter pylori infection is associated with the risk and phenotypes of cholelithiasis: A multi-center study and meta-analysis1 passage
• Meta-analysis on the epidemiology of gastroesophageal reflux disease in China1 passage
• Minocycline in the eradication of Helicobacter pylori infection: A systematic review and meta-analysis1 passage
• Regional multi-center randomized trial of three vonoprazan-amoxicillin dosing regimens for Helicobacter pylori eradication in Sichuan Province, China1 passage
• Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis1 passage
• Vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication in Chinese population: A prospective, multicenter, randomized, two-stage study1 passage